Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy

Zoya Kurago, Gang Guo, Huidong Shi, Roni J. Bollag, Michael W. Groves, J. Kenneth Byrd, Yan Cui

Research output: Contribution to journal › Short survey › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences